Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 217 for “"formulation development"”.

  1. Formulation Development of Anti-Cancer Drugs

    Formulation issues, including stability, solubility and bioavailability, have been identified as key concerns in anti-cancer drug development. The challenges in pharmaceutical formulation often arise from the different physicochemical attributes of a molecule and the need to deliver the compound to …

    ku Repository record for Formulation Development of Anti-Cancer Drugs (opens in a new tab)

  2. Solubilization of drugs. Formulation development perspective

    … consequences of the dilution of a pH solubilized formulation are evaluated by means of two in vitro formulation dilution methods.

    arizona-thes Repository record for Solubilization of drugs. Formulation development perspective (opens in a new tab)

  3. Formulation development of anticancer drug: FB642

    … overall aim of this research was to conduct preformulation studies and develop therapeutically viable oral and parenteral formulations. The solubility of carbendazim was altered by using both solute and solvent modification approaches. The solvent modification was carried out by investigating …

    arizona-thes Repository record for Formulation development of anticancer drug: FB642 (opens in a new tab)

  4. Retinoids: Formulation development and efficacy evaluation in melanoma cells

    … and tumor model of melanoma. Cyclodextrin-based formulations of retinoids were subsequently developed to improve their solubility, photostability and bioavailability, and molecular modeling was carried out to verify the complexation of retinoids by cyclodextrins. Pharmacokinetic properties of the …

    nus Repository record for Retinoids: Formulation development and efficacy evaluation in melanoma cells (opens in a new tab) Download file for Retinoids: Formulation development and efficacy evaluation in melanoma cells (opens in a new tab)

  5. Preformulation and Formulation Development of a Novel Radioprotectant Drug

    … NaOH (0.05 N) or hydrogen peroxide(1.5% v/v). Preformulation studies included determination of microscopic and macroscopic properties, partition coefficient, pKa, pH-dependant solubility, pH-dependant stability, solid-state characterization and solid-state stability. XRD (X ray diffraction) and …

    creighton Repository record for Preformulation and Formulation Development of a Novel Radioprotectant Drug (opens in a new tab) Embargoed until 2100-01-01

  6. Formulation development strategies for oral extended release dosage form

    … coated pellets. The latter was the most robust formulation. The difference of BE verapamil HCl releases could be attributed to the high surface tension in vitro, which led to the decreased drug release. Compendial in vitro dissolution methods used in this study were not discriminating because …

    fu-berlin Repository record for Formulation development strategies for oral extended release dosage form (opens in a new tab)

  7. Dual centrifugation - a novel perspective on lipid nanoparticle formulation development

    … has revolutionized modern medicine. However, the development and manufacturing of delivery systems, particularly of lipid nanoparticles (LNPs), remain a key challenge. Current formulation techniques face significant setbacks in terms of reproducibility, flexibility, time, and resource consumption. …

    freiburg-diss Repository record for Dual centrifugation - a novel perspective on lipid nanoparticle formulation development (opens in a new tab)

  8. FORMULATION DEVELOPMENT, CHARACTERIZATION, AND OPTIMIZATION OF ANTIMALARIAL AND ANTIBIOTIC DRUGS

    … on the physicochemical properties of lipid formulations. To investigate the drug release mechanisms from the lipid-based formulations, empirical release kinetic models such as zero-order, Higuchi, Korsmeyer-Peppas, and Hixson-Crowell were used. In an ex vivo hemolysis toxicity study, the …

    mississippi Repository record for FORMULATION DEVELOPMENT, CHARACTERIZATION, AND OPTIMIZATION OF ANTIMALARIAL AND ANTIBIOTIC DRUGS (opens in a new tab)

  9. Formulation Development of Natamycin Loaded Nanoemulsion for Ocular Drug Delivery

    … concentrations to be carried forward with NT-NE development. NT-NE were prepared by hot homogenization and ultra-probe sonication method, using Castor oil (CO) and Miglyol 812 as liquid lipids, Tween®80 and Poloxomer 188 as surfactants. NT-NE were characterized for physicochemical properties such …

    mississippi Repository record for Formulation Development of Natamycin Loaded Nanoemulsion for Ocular Drug Delivery (opens in a new tab)

  10. Formulation development of drug nanocrystals and nanoparticles for dermal delivery

    … represent the leading technology for drugs, the formulation of which is problematic due to their low solubility in water and oils, high melting temperature and high molecular weight, because the need for solubilization is obviated by maintaining the drug in a solid crystalline state. Moreover, …

    fu-berlin Repository record for Formulation development of drug nanocrystals and nanoparticles for dermal delivery (opens in a new tab)

  11. Overcoming challenges of solid dosage formulation development by using emerging technologies

    … challenges when developing them. During the formulation development process, critical quality attributes (CQAs) of a drug product must be carefully controlled, and they are typically influenced by critical material attributes (CMAs) and critical processing parameters (CPPs). A conventional …

    texas Repository record for Overcoming challenges of solid dosage formulation development by using emerging technologies (opens in a new tab)

  12. Formulation development of a novel antivirulence compound for enhanced pharmacokinetic properties

    … However, its clinical use is restricted by formulation challenges arising from its poor aqueous solubility. In this dissertation, plate-like or tube-like C790 nanoparticles with thickness down to one hundred nanometers have been successfully produced using antisolvent precipitation- …

    missouri Repository record for Formulation development of a novel antivirulence compound for enhanced pharmacokinetic properties (opens in a new tab)

  13. Formulation Development of High Dose (-)-Epigallocatechin-3-gallate Immediate Release Tablets

    … of EGCG with excipients is crucial for the formulation development. First of all, the autoxidative degradation of EGCG in aqueous solution was investigated and showed that the degradation occurs at pH ≥ 5 and follows a biphasic degradation pattern with a first fast degradation phase which is …

    fu-berlin Repository record for Formulation Development of High Dose (-)-Epigallocatechin-3-gallate Immediate Release Tablets (opens in a new tab)

  14. Advancing energetic material science through high-energy density formulation development and characterization

    … to enhance the deflagration zone of explosive formulations. However, due to incomplete combustion, the alumina passivation barrier, and the consumption of available oxygen in energetic formulations, Al still poses as a diffusion limitation to ideal reaction rates. Enter aluminum iodate …

    ttu Repository record for Advancing energetic material science through high-energy density formulation development and characterization (opens in a new tab) Embargoed until 2027-05-01

  15. Orally disintegrating tablets: formulation development, novel engineering solutions and fixed dose combinations

    … ODTs and fixed dose combination (FDC) formulations are popular as they improve patient compliance and combination of the two has not previously been explored. The requirement for ODTs to disintegrate rapidly whilst also being mechanically robust means that high drug loading is a …

    aston Download PDF for Orally disintegrating tablets: formulation development, novel engineering solutions and fixed dose combinations (opens in a new tab)

  16. Pseudomonas chlororaphis strain PA23 plant growth promotion characteristics and product formulation development.

    … were significantly larger. Liquid- and dry-based formulations were investigated for their impact on PA23 cell viability over the course of 1 year at 4oC. Liquid formulations contained PA23 cells suspended in LB with one or more additives to protect against desiccation. For dry formulations, PA23 …

    manitoba Repository record for Pseudomonas chlororaphis strain PA23 plant growth promotion characteristics and product formulation development. (opens in a new tab)

  17. Preventing Physical Degradation of LABL-Fc-MOG BPI with Formulation Development Approaches

    … stability, precipitating rapidly under standard formulation conditions. This study employed a high-throughput, multi-phase formulation development strategy to enhance its conformational and colloidal stability. In Phase 1, intrinsic fluorescence differential scanning fluorometry (IF-DSF) and PEG …

    ku Repository record for Preventing Physical Degradation of LABL-Fc-MOG BPI with Formulation Development Approaches (opens in a new tab)

Page 1 of 11